ABSTRACT We have produced hybridoma antibodies directed against immunoglobulins present in the cerebrospinal fluid ofa patient with multiple sclerosis (MS). One hybridoma antibody recognized an idiotypic determinant of an immunoglobulin population [an idiotype (Id)] which constituted approximately 1% of the immunoglobulin present in the cerebrospinal fluid. The Id focused in the pH range 8. 0-8.4. It was present at roughly 10-to 15-fold higher relative (compared to total immunoglobulin) concentration in cerebrospinal fluid than in serum of the homologous MS patient. The Id could not be detected in three cerebrospinal fluid samples and 28 serum samples of heterologous MS patients or in the serum of 43 optic neuritis patients. The Id persisted in the homologous MS patient at increased concentration over the entire (6 years) observation period. The Id could be shown to react with a Theiler murine encephalomyelitis virus strain WW which was isolated from mice after inoculation with periplaque white matter from brain in a histologically confirmed case of MS.
The cerebrospinal fluid (CSF) ofpatients with multiple sclerosis (MS) frequently contains restricted (oligoclonal) populations of Igs that are increased in concentration relative to other CSF Ig populations (1) (2) (3) (4) (5) and are thought to be produced by intrathecally localized B cells (6) (7) (8) (9) . Many attempts have been made to identify the specificity ofthese predominant CSF Ig populations in the hope offinding some clues to the nature of the antigen(s) involved in the pathogenesis of MS. Those studies have revealed predominant CSF Ig populations reactive with various viruses, most notably measles (reviewed in ref. 10 ) and, in one case, reactive with smooth muscle antigens (11) . These antibodies seem to account, however, only for a minor fraction of the oligoclonal Ig (12) (13) (14) . Thus, the specificity(ies) of most of the predominant Ig populations in the CSF of MS patients remains unknown.
Recent studies by Baird et al. (15) and Nagelkerken et al. (16) have demonstrated the feasibility of producing anti-idiotypic antibodies by immunization of mice and guinea pigs, respectively, with CSF Ig of MS patients. Such anti-idiotypic antibodies may provide ideal reagents for investigation of the specificity ofpredominant CSF 1g. The present study describes the production of one such anti-idiotypic hybridoma antibody and its application in specificity analyses ofa predominant CSF Ig population.
MATERIALS AND METHODS CSF and Serum Specimens. Twenty-eight serum and three CSF specimens were obtained from 28 Scandinavian MS patients (Department ofNeurology, University ofLund, Sweden). The CSF from patient 1, a 47-year-old man with a history of MS for 29 years, was used as immunogen or immunoadsorbent in the radioimunoassay (RIA). Between 1974 and 1976, this patient had no exacerbations but was slowly deteriorating and has continued to do so. Pooled and concentrated CSF collected from this patient between 1974 As controls, serum samples from 14 healthy Scandinavians were obtained, and a normal Ig pool was prepared from serum samples of 70 healthy North Americans. The pooled serum was precipitated with ammonium sulfate at 42% saturation. The precipitate was then redissolved in and dialyzed against 0.1 M K phosphate buffer at pH 7.4 and subsequently purified on DE-32 as described for CSF Ig.
Production of Murine Anti-CSF-Ig Hybridomas. A/J mice were immunized by four intraperitoneal inoculations with 100 ,ug of Ig (1:9 in complete Freund's adjuvant) partially purified from pooled (1974) (1975) (1976) concentrated CSF from MS patient 1 (15) . One ofthe mice (kindly provided by Lynn Baird) was given a booster of200 ,ug ofhomologous DE-32 CSF Ig in phosphatebuffered saline administered intravenously and sacrificed 3 days later. Mouse splenocytes were then fused with P3X63 Ag8 myeloma cells (17) according to standard procedures (18) , and 480 initial cultures were seeded in flat-bottom microtiter plates (Linbro) at a density of 2 x 105 splenocytes per well. Growing hybrid cultures were screened for anti-Ig antibody production in RIA. Selected hybrid cultures were cloned on soft agar. For use in the competition RIA (see below), hybridomas were kept in serum-free Dulbecco's modified Eagle's medium containing 0.1% bovine serum albumin, and the secreted antibodies were concentrated and partially purified by ion exchange chromatography. Briefly, the culture medium was dialyzed against 0. (19) . Test samples were diluted in phosphate-buffered saline containing 0.04% NaN3 and 10% agamma horse serum (HAS/HS) and incubated with the immunoadsorbents. For murine antibody samples, bound antibody was determined by subsequent incubation with radioiodinated rabbit anti-mouse F(ab')2 antibodies; for human antibody samples, subsequent incubation was with mouse anti-human Ig hybridoma antibodies followed by iodinated rabbit anti-mouse F(ab')2 antibodies.
Competition RIA was used to determine the concentration Immunoprecipitation. lodinated DE-32-purified CSF Ig was incubated for 30 min at room temperature with murine antihuman Ig hybridoma antibodies and precipitated with Sepharose 4B beads coupled with affinity-purified rabbit anti-mouse F(ab')2 antibodies. The beads were washed extensively, extracted in NaDodSO4 sample buffer, electrophoresed under reducing conditions in NaDodSOJpolyacrylamide gels, and fluorographed as described (19) .
Isoelectric Focusing. This was done as described (22) in 3-ml sucrose gradients (5-25%) containing a mixture of ampholytes (Bio-Lyte, Bio-Rad) of pH 4-6, pH 6-8, and pH 8-10 at final concentrations of0.3%, 1.3%, and 1.0%, respectively, and containing 5% serum from patient 1. After electrophoresis for 6 (Fig. 3, triangles) contained concentrations of Ig molecules reactive with H9-5 and A12-2 similar to those of the patient's serum but completely lacked the A4-5-reactive-Ig molecules, suggesting that A4-5 recognizes determinants unique to the Ig of patient 1.
The relative concentration of A4-5-reactive Ig molecules remained, compared to the concentration of H9-5-reactive Ig molecules, 10-to 15-fold increased in the CSF ofpatient 1 over a 6-year observation period ( Table 2 ). Absence of A4-5-Reactive Ig Molecules in Heterologous CSF and Sera. CSF samples from two heterologous MS patients and serum samples from 28 MS and 43 ON patients were tested in the competition RIA for the presence of A4-5-reactive Ig molecules. None of these samples inhibited the reaction of A4-5 with iodinated CSF Ig ofpatient 1 significantly more than did pooled normal serum Ig. The serum of the sister of patient 1, who also has MS, lacked detectable amounts of A4-5-reactive Ig. However, the threshold of detection of A4-5-reactive Ig molecules in serum samples was only approximately 1/40th the concentration of A4-5-reactive Ig in the serum of patient 1 because the latter serum diluted 1:50 and normal serum undiluted both produced 50% competition. High serum concentrations tend to interfere nonspecifically in this competition RIA. Specificity of the A4-5-Reactive Ig. The serum of patient 1 was screened in the indirect RIA for the presence of antibodies binding to various immunoadsorbents (Table 3) . By using hybridoma antibody H9-5 (which reacts with a large fraction of (23) . Although the WW virus was subsequently shown to have the same overall polypeptide composition as TMEV strains of low neurovirulence (24) and although TMEV are indigenous murine enteroviruses (27) that occasionally gain access to the central nervous system and produce spontaneous encephalomyelitis in mice (28) , the WW isolate should not be dismissed on this basis as an artifact of the isolation experiments. First, it is well documented that many viruses are pathogenic for humans and mice. Second, the isolation of "TMEV-related" virus from a Siberian tribe suffering from endemic "poliomyelitis-like" central nervous system disease (Vilyuisk encephalitis) has been reported (29) . Interestingly, the Vilyuisk encephalitis typically showed a biphasic course with an early acute and a chronic late phase, which is strikingly similar to experimental TMEV-induced disease in mice (30 The~pathogenic significance ofpredominant CSF Ig with antiviral activity in MS patients is controversial. Previous investigations have shown that many different antiviral specificities, often within the CSF of one MS patient (10, 13, 31) , are associated with predominant CSF Ig populations and that Ig spectrotypes eluted from individual plaques of the same MS brain differ, at least in part, from plaque to plaque (26) . It has been suggested, therefore, that the predominant CSF.Igs result from nonspecific trapping ofcirculating precursor B cells in MS brain lesions and their subsequent stimulation by local mitogen(s) (10, 13, 26, 31) . However, this hypothesis is difficult to reconcile with the observation that the most frequently observed specificities of predominant CSF Ig populations are against potentially neurotropic viruses such as measles, mumps, rubella, var-.icella, and herpes but not against ubiquitous pneumotropic viruses such as influenza. Also,. it is difficult to envision how the restricted population of B cells committed for secretion of the Id could persist for at least 6 years. in the absence of a specific regulatory mechanism. Of course, we cannot specify at this point whether the Id persisted because of an aberrant B cell regulation (32) (33) (34) or because ofan ongoing stimulation by WW virus, an antigenically related virus, or.even a nonviral immunogen. Nonetheless, in view ofthe isolation ofthe WW virus and the observation that after a latent period of 1-5 months TMEV of low neurovirulence induces chronic demyelinating central nervous system disease in mice (30, 35) , the present finding warrants a careful examination ofthe possible role ofthis virus in MS. In, addition, analysis of a larger spectrum of predominant CSF Ig populations by means of anti-idiotypic antibodies may provide further insight into the pathogenic significance of the intrathecally produced antibodies in MS patients.
